A randomized open-label study of darbepoetin alfa administered every 3 weeks with or without parenteral iron in anemic subjects with nonmyeloid malignancies receiving chemotherapy No significant ...

W.L. Gore & Associates announced today that the FDA approved its Viabahn Fortegra venous stent, formerly known as Viafort.

Based on type, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous vascular access device, and accessories. Among these, in ...

It is common practice to insert totally implantable venous access devices (TIVADs) in cancer patients beginning a course of chemotherapy to eliminate potential peripheral venous access problems; ...

The largest study of patients with peripherally inserted central catheters (PICC) utilizing a subcutaneous anchoring securement system (SASS) ever conducted shows that using subcutaneous anchors to ...

BEDFORD, Mass.--(BUSINESS WIRE)--Access Vascular, Inc. today announced FDA clearance of its HydroMID™ midline catheter. HydroMID, which is made of Access Vascular’s proprietary biomaterial that has ...

Lawyers say Bard's PowerPort devices, which pump intravenous chemotherapy and other fluids injected into the bloodstream, could generate up to 10,000 lawsuits. In 2019, the U.S. Food and Drug ...

BEDFORD, Mass.--(BUSINESS WIRE)--Access Vascular, Inc., a company addressing the most common and costly venous access complications, today announced it has closed on a Series B round of financing. TVM ...

The MarketWatch News Department was not involved in the creation of this content. "Intravenous (IV) therapy and vein access play a crucial role in delivering medications, fluids and nutrients directly ...